TrainerMD, Styku use gaming console to produce 3D body scans

The Microsoft Xbox Kinect isn't just for video games. TrainerMD, producers of HIPAA-compliant software for patients and clinicians, has paired with Styku, a software and Microsoft Accelerator company, to utilize the machine as a 3D body scanner.

The Styku 3D Body Scan takes millions of pictures, which TrainerMD’s platform can compile into a complete scan in just 30 seconds. Whether their trying to lose weight or improve their posture, patients are able to visually see their changes and progress through the Kinect. Physicians and trainers are also able to view the changes in a patient’s body and make recommendations for improvement.

"We are looking forward to bringing this to our members, offering them instant insights into their fitness progression, while giving their trainers, physical therapists and physicians instantaneous access to the same data for real-time risk assessment and treatment," said TrainerMD CEO and founder Joe Howley

As well as gaining access to the Kinect, TrainerMD subscribers are able to attend two physician led support workshops every month, receive nutrition education, fitness coaching, rewards and accountability to keep them on track to achieving their health goals.

"This is uncharted territory for all of us, but by joining forces, we have a real opportunity to make a difference in the lives of millions of healthcare consumers by automating delivery of 360-degree healthcare intelligence," said Raj Sareen, CEO of Styku. "The combination of our leading edge technologies offers the most advanced, sophisticated ways to capture and share health and nutrition data on the market."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.